More articles from Commentary

You have access
Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
Vaibhav Deokar, Alok Sharma and Subrahmanyam M. Volety

PDA Journal of Pharmaceutical Science and Technology March 2025, 79 (2) 218-235; DOI: https://doi.org/10.5731/pdajpst.2023.012873
You have access
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
Jennifer Anderson, Chelsea Burgwin and Donna Hamilton

PDA Journal of Pharmaceutical Science and Technology April 2025, pdajpst.2024-003024; DOI: https://doi.org/10.5731/pdajpst.2024-003024.1
You have access
Expanding the Use of Moist Heat for Terminal Sterilization
James Agalloco

PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 114-121; DOI: https://doi.org/10.5731/pdajpst.2023.012918
You have access
Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Dennis Jenke, Piet Christiaens and Ted Heise

PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 98-113; DOI: https://doi.org/10.5731/pdajpst.2024.012945
You have access
A Commentary on “Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit”
Félix A. Montero Julian

PDA Journal of Pharmaceutical Science and Technology November 2024, 78 (6) 730-734; DOI: https://doi.org/10.5731/pdajpst.2024.012995
You have access
A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI’s CMC Framework
Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier and Ingrid Kromann

PDA Journal of Pharmaceutical Science and Technology September 2024, 78 (5) 613-623; DOI: https://doi.org/10.5731/pdajpst.2023.012912
You have access
Demonstrating Results Equivalence of Bacterial Endotoxins Test Methods
Steven Walfish, John Duguid and Karen McCullough

PDA Journal of Pharmaceutical Science and Technology July 2024, 78 (4) 501-511; DOI: https://doi.org/10.5731/pdajpst.2023.012871
You have access
Accurate or Protective: What Is the Goal of Non-Targeted Extractables and Leachables Quantitation and Identification?
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology May 2024, 78 (3) 358-366; DOI: https://doi.org/10.5731/pdajpst.2023.012868
You have access
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and Other Drug-–Device Combination Products
Cheryl L. M. Stults, Christine L. Lanning, Lee M. Nagao and James Conners

PDA Journal of Pharmaceutical Science and Technology January 2024, 78 (1) 125-139; DOI: https://doi.org/10.5731/pdajpst.2023.012852
You have access
Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony-Forming Unit
Joanny Salvas, Petra Merker, Mike Dingle, Cedric Joossen, Chris Knutsen, David Govezensky, Jim Cannon, Philip Villari, Anthony Cundell, Victoria Navarro, Margit Franz-Riethdorf and Allison Scott

PDA Journal of Pharmaceutical Science and Technology November 2023, 77 (6) 514-518; DOI: https://doi.org/10.5731/pdajpst.2022.012790

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.